Received Mar 13, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | UNK | — |
an allergic reaction to the Menveo; This non-serious case was reported by a physician via other manufacturer and described the occurrence of allergy to vaccine in a 22-year-old female patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced allergy to vaccine (Verbatim: an allergic reaction to the Menveo). The outcome of the allergy to vaccine was not reported. It was unknown if the reporter considered the allergy to vaccine to be related to Menveo. It was unknown if the company considered the allergy to vaccine to be related to Menveo. Additional Information: GSK Receipt Date: 06-MAR-2026 The patient had an allergic reaction to the Menveo vaccine had not started taking medication. The batch number was not provided and we and unable to contact the reporter.